[1]
|
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71: 209-249. doi: 10.3322/caac.21660 |
[2]
|
Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study[J]. Lancet Oncol, 2021, 22: 1002-1013. doi: 10.1016/S1470-2045(21)00199-6 |
[3]
|
Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70: 145-164. doi: 10.3322/caac.21601 |
[4]
|
Davidson KW, Barry MJ, Mangione CM, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement[J]. JAMA, 2021, 325: 1965-1977. doi: 10.1001/jama.2021.6238 |
[5]
|
Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society[J]. CA Cancer J Clin, 2018, 68: 250-281. doi: 10.3322/caac.21457 |
[6]
|
国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组. 中国结直肠癌筛查与早诊早治指南(2020, 北京)[J]. 中华肿瘤杂志, 2021, 43: 16-38. doi: 10.3760/cma.j.cn112152-20210105-00010 |
[7]
|
Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer[J]. Lancet, 2019, 394: 1467-1480. doi: 10.1016/S0140-6736(19)32319-0 |
[8]
|
Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know[J]. Gut, 2015, 64: 1327-1337. doi: 10.1136/gutjnl-2014-308074 |
[9]
|
Peng L, Balavarca Y, Weigl K, et al. Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening[J]. Am J Gastroenterol, 2019, 114: 1520-1530. doi: 10.14309/ajg.0000000000000370 |
[10]
|
Chen H, Li N, Shi J, et al. Comparative evaluation of novel screening strategies for colorectal cancer screening in China(TARGET-C): a study protocol for a multicentre randomised controlled trial[J]. BMJ Open, 2019, 9: e025935. doi: 10.1136/bmjopen-2018-025935 |
[11]
|
Lu M, Zhang Y, Cai J, et al. Head-to-head comparison of a risk-adapted screening strategy using various risk prediction models in detecting colorectal neoplasm[J]. J Gastroenterol Hepatol, 2022, 37: 1244-1252. doi: 10.1111/jgh.15825 |
[12]
|
Sung JJY, Wong MCS, Lam TYT, et al. A modified colorectal screening score for prediction of advanced neoplasia: A prospective study of 5744 subjects[J]. J Gastroenterol Hepatol, 2018, 33: 187-194. |
[13]
|
Chen H, Li N, Ren J, et al. Participation and yield of a population-based colorectal cancer screening programme in China[J]. Gut, 2019, 68: 1450-1457. doi: 10.1136/gutjnl-2018-317124 |
[14]
|
Chiu HM, Ching JY, Wu KC, et al. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms[J]. Gastroenterology, 2016, 150: 617-625. e3. doi: 10.1053/j.gastro.2015.11.042 |
[15]
|
Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multi-target stool DNA testing for colorectal-cancer screening[J]. N Engl J Med, 2014, 370: 1287-1297. doi: 10.1056/NEJMoa1311194 |
[16]
|
Bretthauer M, Kaminski MF, Løberg M, et al. Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial[J]. JAMA Intern Med, 2016, 176: 894-902. doi: 10.1001/jamainternmed.2016.0960 |
[17]
|
王宝权, 柴晓银, 蓝柳豪, 等. 2018-2019年浙江省兰溪市结直肠癌筛查项目成本-效果分析[J]. 中国肿瘤, 2020, 29: 914-918. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU202012005.htm |
[18]
|
陈宏达, 卢明, 刘成成, 等. 结肠镜、免疫法粪便隐血试验和新型风险评估筛查方案在人群结直肠癌筛查中的参与率比较及其影响因素分析[J]. 中华流行病学杂志, 2020, 41: 1655-1661. |
[19]
|
王乐, 李辉章, 朱陈, 等. 浙江省2013-2018年城市居民结直肠癌筛查结果及成本效果分析[J]. 中华流行病学杂志, 2020, 41: 2080-2086. doi: 10.3760/cma.j.cn112338-20200324-00424 |
[20]
|
Chen H, Lu M, Liu C, et al. Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial(TARGET-C)[J]. Am J Gastroenterol, 2020, 115: 1264-1274. doi: 10.14309/ajg.0000000000000624 |
[21]
|
Chen X, Li H, Guo F, et al. Alcohol consumption, polygenic risk score, and early-and late-onset colorectal cancer risk[J]. EClinicalMedicine, 2022, 49: 101460. |
[22]
|
Ping J, Yang Y, Wen W, et al. Developing and validating polygenic risk scores for colorectal cancer risk prediction in East Asians[J]. Int J Cancer, 2022, 151: 1726-1736. |
[23]
|
Chen H, Liu L, Lu M, et al. Implications of Lifestyle Factors and Polygenic Risk Score for Absolute Risk Prediction of Colorectal Neoplasm and Risk-Adapted Screening[J]. Front Mol Biosci, 2021, 8: 685410. |